ARTICLE | Clinical News
Alexion preclinical data
May 22, 2006 7:00 AM UTC
In a mouse model of acute severe allergic asthma, anti-mouse C5 MAb could be effectively delivered to the lungs to block airway inflammation and hyperresponsiveness. Nebulization of C5 MAb achieved in...